Sign up to save your podcasts
Or
Share MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
The Stock Day Podcast welcomed MIRA Pharmaceuticals, Inc.(Nasdaq:MIRA)(“the Company”), a pre-clinical-stage pharmaceutical development company developing a Novel synthetic THC analog. CEO of the Company, Erez Aminov, joined Stock Day host Kevin Davis following the company’s NASDAQ IPO.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View all episodes
By Stock Day Media
4.4
3131 ratings
The Stock Day Podcast welcomed MIRA Pharmaceuticals, Inc.(Nasdaq:MIRA)(“the Company”), a pre-clinical-stage pharmaceutical development company developing a Novel synthetic THC analog. CEO of the Company, Erez Aminov, joined Stock Day host Kevin Davis following the company’s NASDAQ IPO.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
More shows like Stock Day Media
View all
Bad Friends
14,120 Listeners